Kurt F. Somerville’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-9,020	Closed	-$460K	–	106
2017 Q1	$460K	Sell	9,020 -6,117	-40%	-$283K	0.1%	78
2016 Q4	$565K	Buy	15,137 +5	+0%	+$209	0.13%	75
2016 Q3	$1.02M	Hold	15,132	–	–	0.22%	62
2016 Q2	$840K	Buy	15,132 +2	+0%	+$126	0.19%	62
2016 Q1	$949K	Sell	15,130 -80	-0.5%	-$5.32K	0.22%	61
2015 Q4	$1.43M	Buy	15,210 +2,293	+18%	+$213K	0.33%	55
2015 Q3	$1.04M	Sell	12,917 -310	-2%	-$34.4K	0.26%	58
2015 Q2	$1.58M	Sell	13,227 -160	-1%	-$19.1K	0.37%	51
2015 Q1	$1.4M	Buy	13,387 +105	+0.8%	+$10.6K	0.32%	56
2014 Q4	$1.29M	Buy	13,282 +6,965	+110%	+$645K	0.32%	56
2014 Q3	$493K	Hold	6,317	–	–	0.2%	71
2014 Q2	$400K	Sell	6,317 -475	-7%	-$28.2K	0.16%	81
2014 Q1	$456K	Sell	6,792 -6,693	-50%	-$518K	0.18%	77
2013 Q4	$867K	Sell	13,485 -738	-5%	-$44K	0.33%	57
2013 Q3	$910K	Hold	14,223	–	–	0.36%	57
2013 Q2	$440K	Buy	+14,223	New	+$378K	0.18%	77